Koru Pharma is proud to announce that MESOHEAL® Pink Glow has successfully obtained CE MDR certification, confirming full compliance with the European Union Medical Device Regulation (MDR 2017/745).

This milestone reflects Koru Pharma's ongoing commitment to scientific innovation, product excellence, and regulatory compliance across its global portfolio. As the company continues to expand internationally, obtaining CE MDR certification remains an important step in delivering reliable and clinically supported regenerative aesthetic solutions to practitioners worldwide.

MESOHEAL® Pink Glow is developed to support skin revitalisation and improve overall skin quality through a carefully designed formulation intended for professional aesthetic practice. Receiving CE MDR certification further reinforces confidence in the product's quality and regulatory compliance, providing healthcare professionals and distribution partners with assurance that it satisfies the latest European standards.

Koru Pharma remains dedicated to advancing aesthetic medicine through innovative technologies while maintaining the highest standards of safety, quality, and clinical performance for patients and healthcare professionals around the globe.